Testosterone in men's health: a new role for an old hormone

被引:6
作者
Feeley, Robert J. [1 ]
Saad, Farid [2 ,3 ]
Guay, Andre [4 ]
Traish, Abdulmaged M. [5 ]
机构
[1] Boston Univ, Sch Med, Dept Biochem & Urol, Boston, MA 02118 USA
[2] Bayer Schenng Pharma Mens Healthcare, Berlin, Germany
[3] Gulf Med Univ, Ajman, U Arab Emirates
[4] Lahey Clin Fdn, Ctr Sexual Funct, Dept Endocrinol, Peabody, MA USA
[5] Boston Univ, Sch Med, Ctr Adv Biomed Res, Labs Sexual Med,Inst Sexul Med, Boston, MA 02118 USA
关键词
Testosterone; Metabolic syndrome; Diabetes; Obesity; Vascular disease; Erectile dysfunction; Dyslipidemia; Androgen deficiency; ANDROGEN-DEPRIVATION THERAPY; MIDDLE-AGED MEN; ENDOGENOUS SEX-HORMONES; CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK-FACTORS; LEAN BODY-MASS; METABOLIC SYNDROME; PROSTATE-CANCER; HYPOGONADAL MEN; INSULIN-RESISTANCE;
D O I
10.1016/j.jomh.2009.06.005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Testosterone is an anabolic hormone with a wide range of beneficial effects on men s, health A considerable body of evidence suggests that testosterone (T) deficiency contributes to the onset and/or progression of type 2 diabetes mellitus (T2D) insulin resistance (IR) metabolic syndrome (MEtS) cardiovascular disease (CVD) and erectile dysfunction (ED) Low testosterone precedes elevated fasting insulin glucose, and hemoglobin A1c (HbA1C) values and may even predict the onset of diabetes Low testosterone also produces adverse effects on cardiovascular health Androgen deficiency is associated with increased levels of total cholesterol low density lipoprotein (LDL) increased production of pro-inflammatory factors increased thickness of the arterial wall and contributes to endothelial dysfunction Testosterone therapy of hypogonadal men improves insulin sensitivity fasting glucose and hemoglobin A1c levels Testosterone supplementation restores arterial vaso-reactivity reduces pro-inflammcitory cytokines total cholesterol and triglycende levels and improves endothelial function and high density lipoprotein (HDL) levels The therapeutic role of testosterone in men s health however remains a hotly debated issue for a number of reasons including the purported risk of prostate cancer In view of the emerging evidence suggesting that androgen deficiency is a risk factor for MetS T2D IR, CVD and ED androgen replacement therapy in hypogonadal men may potentially reduce the risk for these pathologie (c) 2009 WPMH GmbH Published by Elsevier Ireland Ltd
引用
收藏
页码:169 / 176
页数:8
相关论文
共 97 条
  • [1] Low testosterone level is an independent determinant of endothelial dysfunction in men
    Akishita, Masahiro
    Hashimoto, Masayoshi
    Ohike, Yurniko
    Ogawa, Surnito
    Iijima, Katsuya
    Eto, Masato
    Ouchi, Yasuyoshi
    [J]. HYPERTENSION RESEARCH, 2007, 30 (11) : 1029 - 1034
  • [2] Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy
    Basaria, S
    Muller, DC
    Carducci, MA
    Egan, J
    Dobs, AS
    [J]. CANCER, 2006, 106 (03) : 581 - 588
  • [3] Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: An inconvenient truth
    Basaria, Shehzad
    [J]. JOURNAL OF ANDROLOGY, 2008, 29 (05): : 534 - 539
  • [4] Metabolic syndrome and coronary heart disease risk in a population-based study of middle-aged men from France and Northern Ireland -: A nested case-control study from the PRIME cohort
    Bataille, V.
    Perret, B.
    Dallongeville, J.
    Arveiler, D.
    Yarnell, J.
    Ducimetiere, P.
    Ferrieres, J.
    [J]. DIABETES & METABOLISM, 2006, 32 (05) : 475 - 479
  • [5] Contribution of age and declining androgen levels to features of the metabolic syndrome in men
    Blouin, K
    Després, JP
    Couillard, C
    Tremblay, A
    Prud'homme, D
    Bouchard, C
    Tchernof, A
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (08): : 1034 - 1040
  • [6] Boyanov M A, 2003, Aging Male, V6, P1
  • [7] Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy
    Braga-Basaria, Milena
    Dobs, Adrian S.
    Muller, Denis C.
    Carducci, Michael A.
    John, Majnu
    Egan, Josephine
    Basaria, Shehzad
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) : 3979 - 3983
  • [8] Low Serum Testosterone Increases Mortality Risk among Male Dialysis Patients
    Carrero, Juan Jesus
    Qureshi, Abdul Rashid
    Parini, Paolo
    Arver, Stefan
    Lindholm, Bengt
    Barany, Peter
    Heimburger, Olof
    Stenvinkel, Peter
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (03): : 613 - 620
  • [9] Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma
    Chen, Z
    Maricic, M
    Nguyen, P
    Ahmann, FR
    Bruhn, R
    Dalkin, BL
    [J]. CANCER, 2002, 95 (10) : 2136 - 2144
  • [10] Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions
    D'Amico, Anthony V.
    Denham, James W.
    Crook, Juanita
    Chen, Ming-Hui
    Goldhaber, Samuel Z.
    Lamb, David S.
    Joseph, David
    Tai, Keen-Hun
    Malone, Shawn
    Ludgate, Charles
    Steigler, Allison
    Kantoff, Philip W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (17) : 2420 - 2425